Quarterly report pursuant to Section 13 or 15(d)

Loans Receivable

v3.23.1
Loans Receivable
3 Months Ended
Mar. 31, 2023
Loans Receivable  
Loans Receivable

8. Loans Receivable

A breakdown of the loans receivable terms and balances are as follows:

Loans receivable

    

March 31, 2023

    

December 31, 2022

Teneo Fund SPVi LLC Note

$

5,911

$

5,911

Pharma EU, LLC Note

1,410

1,410

A&R Note

710

710

SSZ and Elev8 Note

1,002

1,002

Pure Hana Synergy Note

224

224

Little Beach Harvest Note

4,325

2,199

Total loans receivable

$

13,582

$

11,456

Less allowance for expected credit losses

(7,625)

(7,237)

Loans receivable, net of expected credit losses

5,957

4,219

Less current portion of loan receivable

(252)

(516)

Loans receivable, long-term

$

5,705

$

3,703

The Little Beach Harvest loan receivable balance is subject to an interest rate of 9.0%. Accrued interest receivable was $132 as of March 31, 2023 and is included in loans receivable on the condensed consolidated balance sheets. Interest income was $64 and $4 for the three months ended March 31, 2023 and 2022, respectively, and included in interest income on the condensed consolidated statements of income and comprehensive loss.

At each reporting date, the Company assesses whether loans receivables are credit impaired by applying the guidance in ASC 326. A financial asset is considered “credit impaired” when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred. Credit impairment is based on observable data such as significant financial difficulty of the debtor and a breach of contract such as a default or being past due. During the three months ended March 31, 2023, the Company recorded an additional $388 of allowance for expected credit losses due to revised collectability estimates.

Current expected credit loss (“CECL”) reserves are measured by the Company on a probability-weighted basis based on historical experience, current conditions, and reasonable and supportable forecasts. Our assessment includes a variety of factors, including underlying credit, relative maturity dates of the loans, economic considerations, as well as ongoing legal and other regulatory developments in the industry. The process includes consideration for the assumed recovery rate from underlying collateral, with adjustments for time value of money and estimated costs for obtaining and selling the collateral. Given the repayment profile and underlying terms of such loans, CECL reserves are generally estimated over the contractual term of the loan.

The following tables present an analysis of the credit quality of loans receivable, together with impairment losses recognized based on lifetime CECL reserves:

As of March 31, 2023

Nature of collateral

    

Gross amounts

    

Loan losses

    

Net

Security interest in assets of counterparty

$

11,948

(6,177)

$

5,771

Third party guarantee

1,410

(1,224)

186

No collateral

224

(224)

Net loans receivable

$

13,582

$

(7,625)

$

5,957

As of December 31, 2022

Nature of collateral

    

Gross amounts

    

Loan losses

    

Net

Security interest in assets of counterparty

$

9,822

$

(5,915)

$

3,907

Third party guarantee

1,410

(1,098)

312

No collateral

224

(224)

Net loans receivable

$

11,456

$

(7,237)

$

4,219